{
  "id": 3590043,
  "title": "Stryker group president Dylan Crotty sells $144,914 of stock",
  "url": "https://urgent.news/2026/08/26/stryker-group-president-dylan-crotty-sells-144-914-of-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-26T21:01:00.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/stryker-group-president-dylan-crotty-sells-144914-of-stock-93CH-4877959"
  },
  "original_language": "en",
  "account": "Dylan Crotty, President of Stryker Corp, sold 441 shares on August 21, 2026, according to a recent SEC filing. The transaction saw him dispose of the shares at $328.605 each, resulting in a total value of $144,914. Following the sale, Mr. Crotty's ownership of Stryker's stock remains intact, with shares held indirectly through various trusts and accounts. The company's stock price is now $329.70, reflecting a 5% decline year-to-date. Despite the insider sale, analysts view the stock as potentially undervalued, suggesting upside for investors. Stryker Corporation, a healthcare equipment giant, reported stronger-than-expected second-quarter profits, with adjusted earnings of $3.69 per share on $6.6 billion in revenue. This beat estimates of $3.49 per share and $6.58 billion in revenue. Stryker's shares recently saw a raise in price target by Wolfe Research to $375, maintaining an \"Outperform\" rating. The company's organic revenue growth for the first half was approximately 6%, aligning with its full-year guidance of 8.5% to 9%.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}